Halop 5 mg (Tablet)

Unit Price: ৳ 1.00 (10 x 10: ৳ 100.00)

Strip Price: ৳ 10.00

Medicine Details

Category	Details
Generic	Haloperidol
Company	Opsonin pharma ltd

Title

Halop

Description

Halop is a butyrophenone derivative with antipsychotic properties that can manage hyperactivity, agitation, mania, anxiety, and associated psychic disorders.

Color Options

White

Tablet Dosage

Initial dose for adults: 0.5 mg to 3.0 mg 2 to 3 times daily for moderate symptomatology
Severe symptomatology: 3.0 mg to 5.0 mg 2 to 3 times daily
Elderly patients: 0.5 mg to 4.5 mg 2 to 3 times daily
Chronic or Resistant patients: 3.0 mg to 6.0 mg 2 to 3 times daily
Children: A suggested dose for behavior disorders in disturbed and schizophrenic children is 50 microgram per kg body weight

Injection Dosage

Initially 2-10 mg, then every 4-8 hours according to response to total maximum 18 mg daily for schizophrenia and other psychosis, mania
Severely disturbed patients may require an initial dose of up to 18 mg
Elderly (or debilitated) initially half adult dose
Not recommended for children

Pharmacology

Main Properties:
- Antipsychotic
- Antiemetic
Duration of Action: About 12 hours after one single administration
Optimum Daily Therapy: Consists of 2 administrations
Potentiates:
- Action of barbiturates
- General anesthetics
- Other CNS depressant drugs

Indications

Low Doses:
- Nervousness
- Anxiety states
- Irritability
- Insomnia
- Gastrointestinal hypermotility
- Tics
- Stuttering
Higher Doses:
- Psychomotor agitation in mania
- Delusions and hallucinations in schizophrenia
- Choreatic movements
- Behavior and character disorders in children
- Vomiting

Interaction

May Interfere With:
- Anticoagulant properties of phenindione
- Action of epinephrine
- Metabolization of tricyclic antidepressants
May Antagonize:
- Action of sympathomimetic agents
- Blood pressure lowering effects of adrenergic-blocking agents
May Inhibit:
- Antiparkinson effects of levodopa
- Metabolization of tricyclic antidepressants
Enhanced CNS Effects With: Methyldopa

Contraindications

Comatose states and CNS depression due to alcohol or other depressant drugs
Severe depressive states
Lesions of the basal ganglia
Parkinson's syndrome, except in the case of dyskinesias due to levodopa treatment
Sensitivity to haloperidol
Senile patients with pre-existing Parkinson-like symptoms

Side Effects

Headache
Vertigo
Insomnia
Drowsiness
Lethargy
Restlessness
Agitation
Anxiety
Euphoria
Exacerbation of psychotic symptoms
Dry mouth
Blurred vision
Urinary retention
Nausea
Vomiting
Anorexia
Diarrhea
Hypersalivation

Pregnancy & Lactation

Safety not established; do not administer to women of childbearing potential or nursing mothers unless expected benefits outweigh potential hazard to the fetus or child. Haloperidol is excreted in breast milk.

Precautions & Warnings

May lower convulsive threshold
Trigger seizures in known epileptics
Administer cautiously to patients with severe liver or kidney impairment
Caution in patients with pheochromocytoma and predisposing conditions to epilepsy
Possible potentiating effect on potent analgesics or hypnotics

Overdose Effects

Symptoms would be an exaggeration of known pharmacologic effects and adverse reactions, leading to severe extrapyramidal reactions, hypotension, sedation, and potentially a shock-like state